Heading Into 2nd Quarter, CLDX Had a 33% Increase of Funds Buying Shares. (( posted ))
Morning Star and Insider Monkey 6/12/13 To Verify Paste Info Into Google:
With these "truths" under our belt, let's take a look at the key action surrounding Celldex Therapeutics, Inc. (NASDAQ:CLDX).
How are hedge funds trading Celldex Therapeutics, Inc. (NASDAQ:CLDX)?
Heading into Q2, a total of 16 of the hedge funds we track were long in this stock, a change of 33% from one quarter earlier. With hedgies' capital changing hands, there exists a few key hedge fund managers who were increasing their holdings significantly.